References
de Ruiter A, Thin RN. Drugs 47: 297–304, 1994
Wagstaff AJ, et al. Drugs 47: 153–205, 1994
Drwal-Klein LA, O’Donovan CA. Ann Pharmacother 27: 938–949, 1993
McKendrick MW, et al. BMJ 298: 431, 1989
Whitley RJ, Gnann Jr JW. N Engl J Med 327: 782–789, 1992
Scrip 1869: 24, 1993
International valaciclovir HSV study group. Abstracts of the 33rd ICAAC, 341, 1993
Raborn GW, et al. J Am Dent Ass 115: 38–42, 1987
Spruance SL, et al. J Am Dent Ass 161: 185–190, 1990
Scrip 1823: 19, 1993
Committee on Infectious Diseases. Pediatrics 91: 674–676, 1993
Aliaga A, et al. Med Clinica 98: 245–249, 1992
Wutke K, et al. Onkologie 14 (Suppl. 3): 21, 1991
Tyring S, et al. Antiviral Res 23 (Suppl. 1): 73, 1994
Pharm Bus News: 21, 1 Nov 1993
FDC Reports — PinkSheet 55: Te&G11-12, 25 Oct 1993
Pue MA, Benet LZ. Antivir Chem Chemother 4 (Suppl. 1): 47–55, 1993
International valaciclovir zoster study group. Abstracts of the 33rd ICAAC, 240, 1993
Beauchamp LM, Krenitsky TA. Drugs Fut 18: 619–628, 1993
Weller S, et al. Antiviral Res 20 (Suppl. 1): 144, 1993
Rights and permissions
About this article
Cite this article
Aciclovir dominates the management of common herpesvirus infections. Drugs Ther. Perspect 3, 1–4 (1994). https://doi.org/10.2165/00042310-199403090-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199403090-00001